Bad Blood: Secrets and Lies in a Silicon Valley Startup (Paper Back)

8,550Ks

Creamy Paper…..! / Premium Quality….!

Categories: ,

Description

THE FINANCIAL TIMES & MCKINSEY BUSINESS BOOK OF THE YEAR
NEW YORK TIMES NOTABLE BOOK
A WASHINGTON POST NOTABLE BOOK

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion.